EX-23.2 3 a12-11092_1ex23d2.htm EX-23.2

Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Synta Pharmaceuticals Corp. Amended and Restated 2006 Stock Plan of our reports dated February 22, 2012, with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting of Synta Pharmaceuticals Corp., included in its Annual Report (Form 10-K) for the year ended December 31, 2011, filed with the Securities and Exchange Commission.

 

 

/s/ Ernst & Young LLP

 

Boston, Massachusetts

May 3, 2012